ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
02 2021
Historique:
received: 10 06 2020
revised: 03 07 2020
accepted: 15 07 2020
pubmed: 22 7 2020
medline: 15 1 2021
entrez: 22 7 2020
Statut: ppublish

Résumé

It has been suggested that some individuals may present genetic susceptibility to SARS-CoV-2 infection, with particular research interest in variants of the ACE2 and TMPRSS2 genes, involved in viral penetration into cells, in different populations and geographic regions, although insufficient information is currently available. This study addresses the apparently reasonable hypothesis that variants of these genes may modulate viral infectivity, making some individuals more vulnerable than others. Through whole-exome sequencing, the frequency of exonic variants of the ACE2, TMPRSS2, and Furin genes was analyzed in relation to presence or absence of SARS-CoV-2 infection in a familial multiple sclerosis cohort including 120 individuals from Madrid. The ACE2 gene showed a low level of polymorphism, and none variant was significantly associated with SARS-CoV-2 infection. These variants have previously been detected in Italy. While TMPRSS2 is highly polymorphic, the variants found do not coincide with those described in other studies, with the exception of rs75603675, which may be associated with SARS-CoV-2 infection. The synonymous variants rs61735792 and rs61735794 showed a significant association with infection. Despite the limited number of patients with SARS-CoV-2 infection, some variants, especially in TMPRSS2, may be associated with COVID-19.

Identifiants

pubmed: 32691890
doi: 10.1002/jmv.26319
pmc: PMC7404937
doi:

Substances chimiques

Receptors, Virus 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23
Serine Endopeptidases EC 3.4.21.-
TMPRSS2 protein, human EC 3.4.21.-
FURIN protein, human EC 3.4.21.75
Furin EC 3.4.21.75

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

863-869

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

J Virol. 2014 Jan;88(2):1293-307
pubmed: 24227843
Front Genet. 2020 Aug 04;11:872
pubmed: 32849840
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Transl Res. 2007 Dec;150(6):374-80
pubmed: 18022600
J Biomol Struct Dyn. 2021 Jul;39(10):3576-3593
pubmed: 32410502
J Neurol Sci. 2016 Apr 15;363:29-32
pubmed: 27000216
BMC Infect Dis. 2006 May 04;6:82
pubmed: 16672072
Biochem Biophys Res Commun. 2004 Jul 9;319(4):1216-21
pubmed: 15194496
BMC Med Genet. 2013 Nov 05;14:117
pubmed: 24191856
Brain Behav. 2019 Apr;9(4):e01272
pubmed: 30900415
Emerg Microbes Infect. 2020 Dec;9(1):155-168
pubmed: 31964246
Med Hypotheses. 2020 Oct;143:109893
pubmed: 32512290
Lancet Neurol. 2020 Jun;19(6):481-482
pubmed: 32359409
Commun Biol. 2021 Apr 12;4(1):475
pubmed: 33846513
PLoS One. 2019 Aug 20;14(8):e0221248
pubmed: 31430320
Clin Vaccine Immunol. 2007 Dec;14(12):1644-5
pubmed: 17913858
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
Cell Discov. 2020 Feb 24;6:11
pubmed: 32133153
J Microbiol Immunol Infect. 2020 Jun;53(3):425-435
pubmed: 32414646
Neurologia (Engl Ed). 2020 Apr;35(3):170-175
pubmed: 32299636
PLoS One. 2011;6(8):e23730
pubmed: 21904596
Mult Scler Relat Disord. 2020 Jun;41:102135
pubmed: 32339915
Front Genet. 2020 Jun 08;11:613
pubmed: 32582302
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
Mol Genet Genomic Med. 2020 Aug;8(8):e1344
pubmed: 32558308
Front Public Health. 2020 May 29;8:243
pubmed: 32574308
Twin Res Hum Genet. 2020 Dec;23(6):316-321
pubmed: 33558003
EXCLI J. 2020 Mar 18;19:410-417
pubmed: 32210742
J Int Med Res. 2006 May-Jun;34(3):272-83
pubmed: 16866021
Science. 1980 Aug 22;209(4459):933-4
pubmed: 7403860
Mult Scler Relat Disord. 2020 Sep;44:102297
pubmed: 32554284
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
PLoS One. 2009 Nov 17;4(11):e7870
pubmed: 19924243
J Med Virol. 2021 Feb;93(2):863-869
pubmed: 32691890
BMC Infect Dis. 2007 Jun 01;7:50
pubmed: 17540042
J Virol. 2011 Jan;85(2):873-82
pubmed: 21068237
Infect Genet Evol. 2020 Oct;84:104498
pubmed: 32771700
J Infect. 2015 Jul;71(1):101-9
pubmed: 25818534
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Biochem Biophys Rep. 2020 Dec;24:100798
pubmed: 32844124
Virology. 2007 Oct 25;367(2):367-74
pubmed: 17631932
Eur J Hum Genet. 2020 Nov;28(11):1602-1614
pubmed: 32681121
Mult Scler Relat Disord. 2020 Apr;39:102073
pubmed: 32334820
Mult Scler Relat Disord. 2020 Jul;42:102185
pubmed: 32408147
Mult Scler Relat Disord. 2020 Jul;42:102120
pubmed: 32315980
Aging (Albany NY). 2020 Jun 5;12(11):10087-10098
pubmed: 32501810

Auteurs

Laura Torre-Fuentes (L)

Department of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.

Jorge Matías-Guiu (J)

Department of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.

Laura Hernández-Lorenzo (L)

Department of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.

Paloma Montero-Escribano (P)

Department of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.

Vanesa Pytel (V)

Department of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.

Jesús Porta-Etessam (J)

Department of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.

Ulises Gómez-Pinedo (U)

Department of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.

Jordi A Matías-Guiu (JA)

Department of Neurology, Instituto de Neurociencias IdISSC, Hospital Clínico San Carlos, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH